
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex is a global medical technology company with high growth potential due to its diversified portfolio of critical care and surgical products. Although the company's recent earnings were positive and future growth is anticipated, potential risks remain. With an "Outperform" rating and a price target of $155, analysts expect strong earnings of $40932736 in 2027 and commend the company for its commitment to sustainability in its operations.
Bears say
Teleflex is facing some challenges in the near term, including sales force realignments and supplier recalls. However, with a new CEO bringing proven MedTech leadership and advancements in its Freesolve pipeline, the company is well-positioned for growth in the long term. The planned divestitures and separation into two publicly traded companies also have the potential to drive shareholder value. Risks include slower growth and margin improvements, as well as the potential for dilutive acquisitions.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares